ABUS logo

Arbutus Biopharma Corporation (ABUS)

Profile

Full Name

Arbutus Biopharma Corporation

Ticker

NASDAQ: ABUS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 26, 2007

Indexes

Not included

Website

http://www.arbutusbio.com

Employees

44

Key Details

Price

$3.22(-0.62%)

Market cap

$616.72M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$6.17M(-65.98% YoY)

Annual EPS

-$0.38(+13.64% YoY)

PE ratio

-

Next earnings date

Aug 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.22
    ABUS price is $3.22

    30-Day Relative Volume

    0.51
    ABUS 30-day relative volume is 0.51

    Price Performance

    Price Most recent change

    -0.62%
    ABUS price was down -0.62% on Jul 25, 2025

    Price YTD change

    -1.53%
    ABUS price is down -1.53% since January 1st

    Price 1-year change

    -17.86%
    ABUS price is down -17.86% year-on-year

    Price 3-year change

    +33.61%
    ABUS price is up +33.61% over the past 3 years

    Price Range

    Price All-time high

    $31.48
    ABUS price is currently -89.77% below its historical high of $31.48

    Price 3-year low

    $1.69
    ABUS price is currently +90.53% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $616.72M
    ABUS market capitalization is $616.72 million

    Market cap 3-year change

    +71.98%
    ABUS market capitalization is up +71.98% over the past 3 years

    Market cap All-time high

    $1.05B
    ABUS market capitalization is currently -41.23% below its historical high of $1.05 billion

    Market cap sector rank

    68.43%
    ABUS market capitalization is higher than 68.43% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.48%
    ABUS shares outstanding is up +1.48% year-on-year

    Shares Outstanding 3-Year Change

    +28.72%
    ABUS shares outstanding is up +28.72% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.77
    ABUS beta is 0.77

    200-day SMA

    $3.42
    ABUS price is currently -5.77% below its 200-day simple moving average

    50-day SMA

    $3.29
    ABUS price is currently -2.23% below its 50-day simple moving average

    RSI

    48.88
    ABUS 14-day relative strength index is 48.88

    Volume

    0.51
    ABUS 30-day relative volume is 0.51

    ATR

    $0.11
    ABUS average true range is $0.11

    10-day Historical Volatility

    25.65%
    ABUS 10-day historical volatility is 25.65%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $6.17M
    ABUS annual revenue is $6.17 million

    Revenue Analysts estimate

    $7.83M
    ABUS annual revenue is currently -21.14% lower than the consensus analysts' forecast

    Revenue 1-year change

    -65.98%
    ABUS annual revenue is down -65.98% year-on-year

    Revenue Sector rank

    22.29%
    ABUS annual revenue is higher than 22.29% of companies in Healthcare sector

    EPS

    EPS

    -$0.38
    ABUS annual earnings per share is -$0.38

    EPS Analysts estimate

    -$0.43
    ABUS annual earnings per share is currently -11.63% lower than the consensus analysts' forecast

    EPS 1-year change

    +13.64%
    ABUS annual earnings per share is up +13.64% year-on-year

    EPS Sector rank

    70.29%
    ABUS annual earnings per share is higher than 70.29% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ABUS annual gross profit value is unknown

    Gross margin

    -
    ABUS annual gross profit margin value is unknown

    Operating profit

    -$69.97M
    ABUS annual operating income is -$69.97 million

    Operating margin

    -1133.92%
    ABUS annual operating profit margin is -1133.92%

    Net income

    -$69.92M
    ABUS annual net profit is -$69.92 million

    Net margin

    -1133.04%
    ABUS annual net profit margin is -1133.04%

    Expenses

    Total expenses

    $76.14M
    ABUS annual total expenses is $76.14 million

    Operating expenses

    $76.14M
    ABUS annual total operating expenses is $76.14 million

    Cost of goods sold

    -
    ABUS annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $22.11M
    ABUS annual SGA is $22.11 million

    Depreciation and amortization

    $1.38M
    ABUS annual depreciation & amortization is $1.38 million

    Interest expense

    $137.00K
    ABUS annual interest expense is $137.00 thousand

    Income tax

    $0.00
    ABUS annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$69.78M
    ABUS annual earnings before interest & taxes is -$69.78 million

    EBITDA

    -$68.40M
    ABUS annual EBITDA is -$68.40 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $131.71M
    ABUS annual total assets is $131.71 million

    Non current assets

    $4.39M
    ABUS annual long term assets is $4.39 million

    Current assets

    $127.32M
    ABUS annual total current assets is $127.32 million

    Cash and cash equivalents

    $36.33M
    ABUS annual cash & cash equivalents is $36.33 million

    Accounts receivable

    $2.41M
    ABUS annual accounts receivable is $2.41 million

    Inventory

    -
    ABUS annual inventory value is unknown

    Liabilities

    Total liabilities

    $34.34M
    ABUS annual total liabilities is $34.34 million

    Long term liabilities

    $18.72M
    ABUS annual total long term liabilities is $18.72 million

    Current liabilities

    $15.62M
    ABUS annual total current liabilities is $15.62 million

    Accounts payable

    $2.32M
    ABUS annual accounts payable is $2.32 million

    Debt

    Total debt

    $1.29M
    ABUS annual total debt is $1.29 million

    Total debt 1-year change

    -27.09%
    ABUS annual total debt is down -27.09% year-on-year

    Long term debt

    $806.00K
    ABUS annual long term debt is $806.00 thousand

    Short term debt

    $483.00K
    ABUS annual short term debt is $483.00 thousand

    Equity & Capital

    Shareholders equity

    $97.37M
    ABUS annual stockholders equity is $97.37 million

    Book value

    $97.37M
    ABUS annual book value is $97.37 million

    Retained earnings

    -$1.35B
    ABUS annual retained earnings is -$1.35 billion

    Working capital

    $111.70M
    ABUS annual working capital is $111.70 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$64.85M
    ABUS annual cash flow from operations is -$64.85 million

    Cash from operations 1-year change

    +24.54%
    ABUS annual cash flow from operations is up +24.54% year-on-year

    Cash from investing

    $22.95M
    ABUS annual cash flow from investing activities is $22.95 million

    Cash from investing 1-year change

    -54.8%
    ABUS annual cash flow from investing activities is down -54.8% year-on-year

    Cash from financing

    $52.00M
    ABUS annual cash flow from financing activities is $52.00 million

    Cash from financing 1-year change

    +69.66%
    ABUS annual cash flow from financing activities is up +69.66% year-on-year

    CAPEX

    CAPEX

    $182.00K
    ABUS annual capital expenditures is $182.00 thousand

    CAPEX 1-year change

    -81.94%
    ABUS annual capital expenditures is down -81.94% year-on-year

    Free Cash Flow

    Free cash flow

    -$65.03M
    ABUS annual free cash flow is -$65.03 million

    Free cash flow 1-year change

    +25.2%
    ABUS annual free cash flow is up +25.2% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ABUS annual gross profit margin value is unknown

    Operating margin

    -1133.92%
    ABUS annual operating profit margin is -1133.92%

    Net margin

    -1133.04%
    ABUS annual net profit margin is -1133.04%

    ROA & ROE

    ROA

    -50.65%
    ABUS annual return on assets is -50.65%

    ROE

    -68.76%
    ABUS annual return on equity is -68.76%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ABUS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ABUS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    7.79
    ABUS price to book ratio is 7.79

    PB ratio Sector rank

    85.44%
    ABUS price to book ratio is higher than 85.44% of companies in Healthcare sector

    PS Ratio

    PS ratio

    96.32
    ABUS price to sales ratio is 96.32

    PS ratio Sector rank

    94.13%
    ABUS price to sales ratio is higher than 94.13% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $580.83M
    ABUS enterprise value is $580.83 million

    Enterprise value Sector rank

    67.14%
    ABUS enterprise value is higher than 67.14% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -7.73
    ABUS EV/EBITDA is -7.73

    EV/EBITDA Sector rank

    17.96%
    ABUS EV/EBITDA is higher than 17.96% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    8.15
    ABUS annual current ratio is 8.15

    Quick ratio

    -
    ABUS annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    ABUS annual debt to equity ratio is 0.00

    Interest coverage ratio

    -509.36
    ABUS annual interest coverage ratio is -509.36

    Risk & Stability

    Piotroski F-Score

    -
    ABUS piotroski f-score value is unknown

    Altman Z-Score

    -4.22
    ABUS altman z-score is -4.22

    Analyst ratings

    Recent major analysts updates

    Mar 28, 25 Chardan Capital
    Buy
    Jan 21, 25 HC Wainwright & Co.
    Buy
    Nov 20, 24 Chardan Capital
    Buy
    Nov 18, 24 HC Wainwright & Co.
    Buy
    Nov 7, 24 HC Wainwright & Co.
    Buy
    Nov 7, 24 Chardan Capital
    Buy
    Sep 5, 24 Jefferies
    Buy
    Aug 2, 24 JMP Securities
    Market Outperform
    Jun 7, 24 HC Wainwright & Co.
    Buy
    Jun 6, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with ABUS included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Arbutus Biopharma Corporation?
    • Does Arbutus Biopharma Corporation pay dividends?
    • What sector is Arbutus Biopharma Corporation in?
    • What industry is Arbutus Biopharma Corporation in?
    • What country is Arbutus Biopharma Corporation based in?
    • When did Arbutus Biopharma Corporation go public?
    • Is Arbutus Biopharma Corporation in the S&P 500?
    • Is Arbutus Biopharma Corporation in the NASDAQ 100?
    • Is Arbutus Biopharma Corporation in the Dow Jones?
    • When was Arbutus Biopharma Corporation's last earnings report?
    • When does Arbutus Biopharma Corporation report earnings?

    What is the ticker symbol for Arbutus Biopharma Corporation?

    The ticker symbol for Arbutus Biopharma Corporation is NASDAQ:ABUS

    Does Arbutus Biopharma Corporation pay dividends?

    No, Arbutus Biopharma Corporation does not pay dividends

    What sector is Arbutus Biopharma Corporation in?

    Arbutus Biopharma Corporation is in the Healthcare sector

    What industry is Arbutus Biopharma Corporation in?

    Arbutus Biopharma Corporation is in the Biotechnology industry

    What country is Arbutus Biopharma Corporation based in?

    Arbutus Biopharma Corporation is headquartered in United States

    When did Arbutus Biopharma Corporation go public?

    Arbutus Biopharma Corporation's initial public offering (IPO) was on July 26, 2007

    Is Arbutus Biopharma Corporation in the S&P 500?

    No, Arbutus Biopharma Corporation is not included in the S&P 500 index

    Is Arbutus Biopharma Corporation in the NASDAQ 100?

    No, Arbutus Biopharma Corporation is not included in the NASDAQ 100 index

    Is Arbutus Biopharma Corporation in the Dow Jones?

    No, Arbutus Biopharma Corporation is not included in the Dow Jones index

    When was Arbutus Biopharma Corporation's last earnings report?

    Arbutus Biopharma Corporation's most recent earnings report was on May 14, 2025

    When does Arbutus Biopharma Corporation report earnings?

    The next expected earnings date for Arbutus Biopharma Corporation is August 1, 2025
    On this page